Psychopharmacology of depression in neurologic disorders

J. M. Silver, Robert E Hales, S. C. Yudofsky

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Depression occurs frequently in patients with neurologic disorders. Current research in traumatic brain injury, stroke, Parkinson's disease, multiple sclerosis, epilepsy, and brain tumors indicates that affective symptomatology can be a specific sequel of these illnesses that is related to the resultant impairment in brain functioning. Because of the cognitive and emotional deficits that neurologic disorders can cause, the clinician must be aware of the complicated presentation of depression in these patients. Psychopharmacologic treatments are safe and efficacious in the treatment of depression in patients with neurologic illness.

Original languageEnglish (US)
Pages (from-to)33-39
Number of pages7
JournalJournal of Clinical Psychiatry
Volume51
Issue number1 SUPPL.
StatePublished - 1990
Externally publishedYes

Fingerprint

Psychopharmacology
Nervous System Diseases
Depression
Brain Neoplasms
Nervous System
Multiple Sclerosis
Parkinson Disease
Epilepsy
Stroke
Brain
Therapeutics
Research

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology

Cite this

Psychopharmacology of depression in neurologic disorders. / Silver, J. M.; Hales, Robert E; Yudofsky, S. C.

In: Journal of Clinical Psychiatry, Vol. 51, No. 1 SUPPL., 1990, p. 33-39.

Research output: Contribution to journalArticle

Silver, JM, Hales, RE & Yudofsky, SC 1990, 'Psychopharmacology of depression in neurologic disorders', Journal of Clinical Psychiatry, vol. 51, no. 1 SUPPL., pp. 33-39.
Silver, J. M. ; Hales, Robert E ; Yudofsky, S. C. / Psychopharmacology of depression in neurologic disorders. In: Journal of Clinical Psychiatry. 1990 ; Vol. 51, No. 1 SUPPL. pp. 33-39.
@article{6a4d957bba6b42be85ee978d665bb1f8,
title = "Psychopharmacology of depression in neurologic disorders",
abstract = "Depression occurs frequently in patients with neurologic disorders. Current research in traumatic brain injury, stroke, Parkinson's disease, multiple sclerosis, epilepsy, and brain tumors indicates that affective symptomatology can be a specific sequel of these illnesses that is related to the resultant impairment in brain functioning. Because of the cognitive and emotional deficits that neurologic disorders can cause, the clinician must be aware of the complicated presentation of depression in these patients. Psychopharmacologic treatments are safe and efficacious in the treatment of depression in patients with neurologic illness.",
author = "Silver, {J. M.} and Hales, {Robert E} and Yudofsky, {S. C.}",
year = "1990",
language = "English (US)",
volume = "51",
pages = "33--39",
journal = "Journal of Clinical Psychiatry",
issn = "0160-6689",
publisher = "Physicians Postgraduate Press Inc.",
number = "1 SUPPL.",

}

TY - JOUR

T1 - Psychopharmacology of depression in neurologic disorders

AU - Silver, J. M.

AU - Hales, Robert E

AU - Yudofsky, S. C.

PY - 1990

Y1 - 1990

N2 - Depression occurs frequently in patients with neurologic disorders. Current research in traumatic brain injury, stroke, Parkinson's disease, multiple sclerosis, epilepsy, and brain tumors indicates that affective symptomatology can be a specific sequel of these illnesses that is related to the resultant impairment in brain functioning. Because of the cognitive and emotional deficits that neurologic disorders can cause, the clinician must be aware of the complicated presentation of depression in these patients. Psychopharmacologic treatments are safe and efficacious in the treatment of depression in patients with neurologic illness.

AB - Depression occurs frequently in patients with neurologic disorders. Current research in traumatic brain injury, stroke, Parkinson's disease, multiple sclerosis, epilepsy, and brain tumors indicates that affective symptomatology can be a specific sequel of these illnesses that is related to the resultant impairment in brain functioning. Because of the cognitive and emotional deficits that neurologic disorders can cause, the clinician must be aware of the complicated presentation of depression in these patients. Psychopharmacologic treatments are safe and efficacious in the treatment of depression in patients with neurologic illness.

UR - http://www.scopus.com/inward/record.url?scp=0025129190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025129190&partnerID=8YFLogxK

M3 - Article

VL - 51

SP - 33

EP - 39

JO - Journal of Clinical Psychiatry

JF - Journal of Clinical Psychiatry

SN - 0160-6689

IS - 1 SUPPL.

ER -